Drug: MELPHALAN Injury: Histiocytosis haematophagic Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124203663 | MELPHALAN | Histiocytosis haematophagic | NOVARTIS | 4.00 YR | M | 0 | 20160906 | IN |
126679352 | MELPHALAN | Histiocytosis haematophagic | AVENTIS | 4.00 YR | M | 0 | 20160906 | IN |
126967261 | MELPHALAN | Histiocytosis haematophagic | ACCORD | 4.00 YR | M | 0 | 20160830 | IN |
127009521 | MELPHALAN | Histiocytosis haematophagic | ALKEM | 4.00 YR | M | 0 | 20160831 | GB |
127327851 | MELPHALAN | Histiocytosis haematophagic | MYLAN | 0.00 | 0 | 20160912 | JP | |
127624191 | MELPHALAN | Histiocytosis haematophagic | STRIDES | 0.00 | 0 | 20160920 | JP | |
127765981 | Melphalan | Histiocytosis haematophagic | TEVA | 51.00 YR | M | 0 | 20160923 | JP |
Total Records: 7 Number of Pages: 1